RB Global price target raised to $120 from $116 at BMO Capital
BMO Capital analyst John Gibson raised the firm’s price target on RB Global (RBA) to $120 from $116 and keeps an Outperform rating on the ...
BMO Capital Remains a Buy on Chemours Company (CC)
BMO Capital analyst John McNulty maintained a Buy rating on Chemours Company (CC – Research Report) yesterday and set a price target of $27.00.
Next generation weight loss drugs aim to save muscle
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
Bank of Montreal stock rises Tuesday, still underperforms market
Bank of Montreal closed 2.5% short of its 52-week high of C$147.54, which the company achieved on December 6th.
Albemarle Corporation to Participate in February 2025 Investor Conferences
Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced that Kent Masters, chairman and CEO, is scheduled to ...
Capital One’s new logo is the perfect design (for a completely different brand)
If there's one thing we know about rebrands, it's that many consumers hate change. From the biggest branding evolutions to ...